Eleftheriadis et al. (58) suggests that kynurenine, by competing with hypoxia-inducible factor 2α, may contribute to anemia of inflammation by decreasing erythropoietin and increasing hepcidin production. This evidence concerns the gene EPO and anemia (phenotype).